echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Promoting the development of precision medicine AI-driven single-cell analysis platform receives US$73 million

    Promoting the development of precision medicine AI-driven single-cell analysis platform receives US$73 million

    • Last Update: 2022-04-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 17, 2022, Deepcell announced the completion of a $73 million Series B financing


    Unlike other cell analysis methods, Deepcell's technology is based on the morphological separation and collection of label-free single cells, maintaining cell integrity, which is critical for downstream biological analysis


    Deepcell leverages AI-driven imaging and microfluidic technology platforms that can discover virtually any cell type as the basis for translational research, diagnostic assays, and therapeutic development


    Image source: Deepcell's official website

    Original link: https:// -Platform

    https://
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.